David Coman - Aug 12, 2023 Form 4 Insider Report for Science 37 Holdings, Inc. (SNCE)

Signature
/s/ Christine Pellizzari, Attorney-in-fact for David Coman
Stock symbol
SNCE
Transactions as of
Aug 12, 2023
Transactions value $
-$63,613
Form type
4
Date filed
8/15/2023, 04:30 PM
Previous filing
May 2, 2023
Next filing
Mar 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNCE Common Stock Options Exercise $0 +495K +36.9% $0.00 1.84M Aug 12, 2023 Direct F1
transaction SNCE Common Stock Tax liability -$63.6K -145K -7.87% $0.44 1.69M Aug 12, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNCE Restricted Stock Units Options Exercise $0 -495K -33.33% $0.00 990K Aug 12, 2023 Common Stock 495K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquisition of common stock resulting from vesting of the restricted stock units granted to Mr. Coman on August 12, 2022.
F2 Disposition of common stock resulting from the withholding of securities for the payment of tax liability relating to the vesting of restricted stock units granted to Mr. Coman on August 12, 2022.
F3 Each restricted stock unit represents a contingent right to receive one share of Science 37 Holdings, Inc.'s common stock.
F4 On August 12, 2022, Mr. Coman received restricted stock units representing 1,485,365 shares subject to a three-year vesting schedule, vesting 33 1/3% on the first, second and third anniversaries of the grant date. As restricted stock units vest, the vested units are automatically converted to vested common stock on a one-for-one basis on the vesting date.